New Model of Action for Mood Stabilizers: Phosphoproteome from Rat Pre-Frontal Cortex Synaptoneurosomal Preparations

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Corena McLeod, Maria ^a   Walss Bass, Consuelo ^b   Oliveros, Alfredo ^a   Gordillo Villegas, Andres ^c   Ceballos, Carolina ^d   Charlesworth, Cristine M ^e   Madden, Benjamin ^e   Linser, Paul J ^d   Van Ekeris, Leslie ^d   Smith, Kristin ^a   Richelson, Elliott ^a  

^a MAYO CLINIC   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ACTIN CYTOPLASMIC 1; ALPHA INTERNEXIN; LITHIUM CHLORIDE; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 1; MYOSIN HEAVY CHAIN 2; MYOSIN HEAVY CHAIN 6; NEUROFILAMENT PROTEIN; PALIPERIDONE; TUBULIN; TUBULIN ALPHA 1B CHAIN; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; CELL FUNCTION; CELL MIGRATION; CELL MOTION; CELL TRANSPORT; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HUMAN CELL; MALE; MITOCHONDRION; NERVE CELL PLASTICITY; NONHUMAN; PHOSPHOPROTEOMICS; PREFRONTAL CORTEX; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEIN SUBUNIT; PROTEOMICS; RAT; SCHIZOPHRENIA; SYNAPSE; TANDEM MASS SPECTROMETRY;

ACTINS; AFFECT; ANIMALS; ANTIPSYCHOTIC AGENTS; CELL LINE, TUMOR; ISOXAZOLES; LITHIUM; MALE; MITOCHONDRIA; PHOSPHOPROTEINS; PREFRONTAL CORTEX; PROTEOME; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES; SYNAPTOSOMES; TIME FACTORS; TUBULIN; VALPROIC ACID;

EID: 84877728682     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052147     Document Type: Article

References (95)

1. Uranova NA, Aganova EA, (1989) [Ultrastructure of the synapses of the anterior limbic cortex in schizophrenia]. Zh Nevropatol Psikhiatr Im S S Korsakova 89: 56-59.
2. Whatley SA, Curti D, Das Gupta F, Ferrier IN, Jones S, et al. (1998) Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients. Mol Psychiatry 3: 227-237.
3. Verge B, Alonso Y, Valero J, Miralles C, Vilella E, et al. (2011) Mitochondrial DNA (mtDNA) and schizophrenia. Eur Psychiatry 26: 45-56.
4. Maurer I, Zierz S, Moller H, (2001) Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res 48: 125-136.
5. Mattson MP, Gleichmann M, Cheng A, (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60: 748-766.
6. Corena-McLeod MdelP, Oliveros A, Charlesworth C, Madden B, Liang YQ, et al. (2008) Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression. Brain Res 1233: 8-19.
7. Tilleman K, Van den Haute C, Geerts H, van Leuven F, Esmans EL, et al. (2002) Proteomics analysis of the neurodegeneration in the brain of tau transgenic mice. Proteomics 2: 656-665.
8. Villasana LE, Klann E, Tejada-Simon MV, (2006) Rapid isolation of synaptoneurosomes and postsynaptic densities from adult mouse hippocampus. J Neurosci Methods 158: 30-36.
9. Keller A, Nesvizhskii AI, Kolker E, Aebersold R, (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74: 5383-5392.
10. Nesvizhskii AI, Keller A, Kolker E, Aebersold R, (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75: 4646-4658.
11. Giagtzoglou N, Ly CV, Bellen HJ, (2009) Cell adhesion, the backbone of the synapse: "vertebrate" and "invertebrate" perspectives. Cold Spring Harb Perspect Biol 1: a003079.
12. Arnold SE, Lee VM, Gur RE, Trojanowski JQ, (1991) Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci U S A 88: 10850-10854.
13. Mukaetova-Ladinska EB, Hurt J, Honer WG, Harrington CR, Wischik CM, (2002) Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics. Neurosci Lett 317: 161-165.
14. Benitez-King G, Ramirez-Rodriguez G, Ortiz L, Meza I, (2004) The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia. Curr Drug Targets CNS Neurol Disord 3: 515-533.
15. English JA, Dicker P, Focking M, Dunn MJ, Cotter DR, (2009) 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics 9: 3368-3382.
16. Priel A, Tuszynski JA, Woolf NJ, (2010) Neural cytoskeleton capabilities for learning and memory. J Biol Phys 36: 3-21.
17. Hollenbeck PJ, Saxton WM, (2005) The axonal transport of mitochondria. J Cell Sci 118: 5411-5419.
18. Morris RL, Hollenbeck PJ, (1995) Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons. J Cell Biol 131: 1315-1326.
19. Brodin L, Bakeeva L, Shupliakov O, (1999) Presynaptic mitochondria and the temporal pattern of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci 354: 365-372.
20. Zhai RG, Bellen HJ, (2004) The architecture of the active zone in the presynaptic nerve terminal. Physiology (Bethesda) 19: 262-270.
21. Landis DM, Reese TS, (1983) Cytoplasmic organization in cerebellar dendritic spines. J Cell Biol 97: 1169-1178.
22. Hirokawa N, Sobue K, Kanda K, Harada A, Yorifuji H, (1989) The cytoskeletal architecture of the presynaptic terminal and molecular structure of synapsin 1. J Cell Biol 108: 111-126.
23. Greengard P, Benfenati F, Valtorta F, (1994) Synapsin I, an actin-binding protein regulating synaptic vesicle traffic in the nerve terminal. Adv Second Messenger Phosphoprotein Res 29: 31-45.
24. Li X, Rosahl TW, Sudhof TC, Francke U, (1995) Mapping of synapsin II (SYN2) genes to human chromosome 3p and mouse chromosome 6 band F. Cytogenet Cell Genet 71: 301-305.
25. Pieribone VA, Shupliakov O, Brodin L, Hilfiker-Rothenfluh S, Czernik AJ, et al. (1995) Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375: 493-497.
26. Hilfiker S, Pieribone VA, Czernik AJ, Kao HT, Augustine GJ, et al. (1999) Synapsins as regulators of neurotransmitter release. Philos Trans R Soc Lond B Biol Sci 354: 269-279.
27. Nicol S, Rahman D, Chan KM, Baines AJ, (1998) Interaction of synapsin I with actin and SSVs: differential regulation by calmodulin. Biochem Soc Trans 26: S110.
28. Morales M, Colicos MA, Goda Y, (2000) Actin-dependent regulation of neurotransmitter release at central synapses. Neuron 27: 539-550.
29. Colicos MA, Collins BE, Sailor MJ, Goda Y, (2001) Remodeling of synaptic actin induced by photoconductive stimulation. Cell 107: 605-616.
30. Sankaranarayanan S, Atluri PP, Ryan TA, (2003) Actin has a molecular scaffolding, not propulsive, role in presynaptic function. Nat Neurosci 6: 127-135.
31. Phillips GR, Huang JK, Wang Y, Tanaka H, Shapiro L, et al. (2001) The presynaptic particle web: ultrastructure, composition, dissolution, and reconstitution. Neuron 32: 63-77.
32. Bloom O, Evergren E, Tomilin N, Kjaerulff O, Low P, et al. (2003) Colocalization of synapsin and actin during synaptic vesicle recycling. J Cell Biol 161: 737-747.
33. Zhang W, Benson DL, (2002) Developmentally regulated changes in cellular compartmentation and synaptic distribution of actin in hippocampal neurons. J Neurosci Res 69: 427-436.
34. Dillon C, Goda Y, (2005) The actin cytoskeleton: integrating form and function at the synapse. Annu Rev Neurosci 28: 25-55.
35. Zhao S, Studer D, Chai X, Graber W, Brose N, et al. (2012) Structural plasticity of hippocampal mossy fiber synapses as revealed by high-pressure freezing. J Comp Neurol.
36. Gotow T, Miyaguchi K, Hashimoto PH, (1991) Cytoplasmic architecture of the axon terminal: filamentous strands specifically associated with synaptic vesicles. Neuroscience 40: 587-598.
37. George HJ, Misra L, Field DJ, Lee JC, (1981) Polymorphism of brain tubulin. Biochemistry 20: 2402-2409.
38. Gozes I, Sweadner KJ, (1981) Multiple tubulin forms are expressed by a single neurone. Nature 294: 477-480.
39. Turecki G, Grof P, Grof E, D'Souza V, Lebuis L, et al. (2001) Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry 6: 570-578.
40. Silverman-Gavrila LB, Charlton MP, (2009) Calcineurin and cytoskeleton in low-frequency depression. J Neurochem 109: 716-732.
41. Morciano M, Beckhaus T, Karas M, Zimmermann H, Volknandt W, (2009) The proteome of the presynaptic active zone: from docked synaptic vesicles to adhesion molecules and maxi-channels. J Neurochem 108: 662-675.
42. El Far O, Seagar M, (2011) A role for V-ATPase subunits in synaptic vesicle fusion? J Neurochem 117: 603-612.
43. Sudhof TC, (2004) The synaptic vesicle cycle. Annu Rev Neurosci 27: 509-547.
44. Morel N, Dedieu JC, Philippe JM, (2003) Specific sorting of the a1 isoform of the V-H+ATPase a subunit to nerve terminals where it associates with both synaptic vesicles and the presynaptic plasma membrane. J Cell Sci 116: 4751-4762.
45. Zhang Z, Nguyen KT, Barrett EF, David G, (2010) Vesicular ATPase inserted into the plasma membrane of motor terminals by exocytosis alkalinizes cytosolic pH and facilitates endocytosis. Neuron 68: 1097-1108.
46. Smythe GA, Brandstater JF, Lazarus L, (1979) Acute effects of lithium on central dopamine and serotonin activity reflected by inhibition of prolactin and growth hormone secretion in the rat. Aust J Biol Sci 32: 329-334.
47. Beaulieu JM, Gainetdinov RR, (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63: 182-217.
48. Borcherding DC, Hugo ER, Idelman G, De Silva A, Richtand NW, et al. (2011) Dopamine receptors in human adipocytes: expression and functions. PLoS One 6: e25537.
49. Cai Q, Davis ML, Sheng ZH, (2011) Regulation of axonal mitochondrial transport and its impact on synaptic transmission. Neurosci Res 70: 9-15.
50. Chen S, Owens GC, Crossin KL, Edelman DB, (2007) Serotonin stimulates mitochondrial transport in hippocampal neurons. Mol Cell Neurosci 36: 472-483.
51. Chen S, Owens GC, Edelman DB, (2008) Dopamine inhibits mitochondrial motility in hippocampal neurons. PLoS One 3: e2804.
52. Edelman DB, Owens GC, Chen S, (2011) Neuromodulation and mitochondrial transport: live imaging in hippocampal neurons over long durations. J Vis Exp.
53. Fifkova E, Delay RJ, (1982) Cytoplasmic actin in neuronal processes as a possible mediator of synaptic plasticity. J Cell Biol 95: 345-350.
54. Matus A, Ackermann M, Pehling G, Byers HR, Fujiwara K, (1982) High actin concentrations in brain dendritic spines and postsynaptic densities. Proc Natl Acad Sci U S A 79: 7590-7594.
55. Cohen RS, Chung SK, Pfaff DW, (1985) Immunocytochemical localization of actin in dendritic spines of the cerebral cortex using colloidal gold as a probe. Cell Mol Neurobiol 5: 271-284.
56. Pennington K, Beasley CL, Dicker P, Fagan A, English J, et al. (2008) Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder. Mol Psychiatry 13: 1102-1117.
57. Li Z, Okamoto K, Hayashi Y, Sheng M, (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119: 873-887.
58. Bridgman PC, (2004) Myosin-dependent transport in neurons. J Neurobiol 58: 164-174.
59. Hirokawa N, (1982) Cross-linker system between neurofilaments, microtubules, and membranous organelles in frog axons revealed by the quick-freeze, deep-etching method. J Cell Biol 94: 129-142.
60. Linden M, Nelson BD, Loncar D, Leterrier JF, (1989) Studies on the interaction between mitochondria and the cytoskeleton. J Bioenerg Biomembr 21: 507-518.
61. Leterrier JF, Rusakov DA, Nelson BD, Linden M, (1994) Interactions between brain mitochondria and cytoskeleton: evidence for specialized outer membrane domains involved in the association of cytoskeleton-associated proteins to mitochondria in situ and in vitro. Microsc Res Tech 27: 233-261.
62. Wagner OI, Lifshitz J, Janmey PA, Linden M, McIntosh TK, et al. (2003) Mechanisms of mitochondria-neurofilament interactions. J Neurosci 23: 9046-9058.
63. Kang JS, Tian JH, Pan PY, Zald P, Li C, et al. (2008) Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. Cell 132: 137-148.
64. Minamikawa T, Sriratana A, Williams DA, Bowser DN, Hill JS, et al. (1999) Chloromethyl-X-rosamine (MitoTracker Red) photosensitises mitochondria and induces apoptosis in intact human cells. J Cell Sci 112 (Pt 14):: 2419-2430.
65. Buckman JF, Hernandez H, Kress GJ, Votyakova TV, Pal S, et al. (2001) MitoTracker labeling in primary neuronal and astrocytic cultures: influence of mitochondrial membrane potential and oxidants. J Neurosci Methods 104: 165-176.
66. Rintoul GL, Bennett VJ, Papaconstandinou NA, Reynolds IJ, (2006) Nitric oxide inhibits mitochondrial movement in forebrain neurons associated with disruption of mitochondrial membrane potential. J Neurochem 97: 800-806.
67. Johnson LV, Walsh ML, Bockus BJ, Chen LB, (1981) Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy. J Cell Biol 88: 526-535.
68. Miller KE, Sheetz MP, (2004) Axonal mitochondrial transport and potential are correlated. J Cell Sci 117: 2791-2804.
69. Seo AY, Joseph AM, Dutta D, Hwang JC, Aris JP, et al. (2010) New insights into the role of mitochondria in aging: mitochondrial dynamics and more. J Cell Sci 123: 2533-2542.
70. Morris RL, Hollenbeck PJ, (1993) The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. J Cell Sci 104 (Pt 3):: 917-927.
71. Hollenbeck PJ, (1996) The pattern and mechanism of mitochondrial transport in axons. Front Biosci 1: d91-102.
72. Chada SR, Hollenbeck PJ, (2004) Nerve growth factor signaling regulates motility and docking of axonal mitochondria. Curr Biol 14: 1272-1276.
73. Rintoul GL, Filiano AJ, Brocard JB, Kress GJ, Reynolds IJ, (2003) Glutamate decreases mitochondrial size and movement in primary forebrain neurons. J Neurosci 23: 7881-7888.
74. Rumbach L, Warter JM, Rendon A, Marescaux C, Micheletti G, et al. (1983) Inhibition of oxidative phosphorylation in hepatic and cerebral mitochondria of sodium valproate-treated rats. J Neurol Sci 61: 417-423.
75. Johnston-Wilson NL, Sims CD, Hofmann JP, Anderson L, Shore AD, et al. (2000) Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium. Mol Psychiatry 5: 142-149.
76. Hojlund K, Wrzesinski K, Larsen PM, Fey SJ, Roepstorff P, et al. (2003) Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem 278: 10436-10442.
77. Ali SM, Ahmad A, Shahabuddin S, Ahmad MU, Sheikh S, et al. (2010) Endoxifen is a new potent inhibitor of PKC: a potential therapeutic agent for bipolar disorder. Bioorg Med Chem Lett 20: 2665-2667.
78. Lau CG, Takayasu Y, Rodenas-Ruano A, Paternain AV, Lerma J, et al. (2010) SNAP-25 is a target of protein kinase C phosphorylation critical to NMDA receptor trafficking. J Neurosci 30: 242-254.
79. Fujiyama K, Kajii Y, Hiraoka S, Nishikawa T, (2003) Differential regulation by stimulants of neocortical expression of mrt1, arc, and homer1a mRNA in the rats treated with repeated methamphetamine. Synapse 49: 143-149.
80. Dahl JP, Kampman KM, Oslin DW, Weller AE, Lohoff FW, et al. (2005) Association of a polymorphism in the Homer1 gene with cocaine dependence in an African American population. Psychiatr Genet 15: 277-283.
81. Bornslaeger EA, Corcoran CM, Stappenbeck TS, Green KJ, (1996) Breaking the connection: displacement of the desmosomal plaque protein desmoplakin from cell-cell interfaces disrupts anchorage of intermediate filament bundles and alters intercellular junction assembly. J Cell Biol 134: 985-1001.
82. Stappenbeck TS, Lamb JA, Corcoran CM, Green KJ, (1994) Phosphorylation of the desmoplakin COOH terminus negatively regulates its interaction with keratin intermediate filament networks. J Biol Chem 269: 29351-29354.
83. Morishita H, Yagi T, (2007) Protocadherin family: diversity, structure, and function. Curr Opin Cell Biol 19: 584-592.
84. Takeichi M, (2007) The cadherin superfamily in neuronal connections and interactions. Nat Rev Neurosci 8: 11-20.
85. Arikkath J, Reichardt LF, (2008) Cadherins and catenins at synapses: roles in synaptogenesis and synaptic plasticity. Trends Neurosci 31: 487-494.
86. Langford GM, (2002) Myosin-V, a versatile motor for short-range vesicle transport. Traffic 3: 859-865.
87. Whatley SA, Curti D, Marchbanks RM, (1996) Mitochondrial involvement in schizophrenia and other functional psychoses. Neurochem Res 21 (9):: 995-1004.
88. Prince JA, Blennow K, Gottfries CG, Karlsson I, Oreland L, (1999) Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics. Neuropsychopharmacology 21 (3):: 372-379.
89. Ben-Shachar D, Zuk R, Gazawi H, Reshef A, Sheinkman A, et al. (1999) Increased mitochondrial complex I activity in platelets of schizophrenic patients. Int J Neuropsychopharmacol 2 (4):: 245-253.
90. Ben-Shachar D, (2002) Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem 83 (6):: 1241-1251.
91. Iwamoto K, Bundo M, Kato T, (2005) Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Human Molecular Genetics 14 (2):: 241-253.
92. Smith DF, (1976) Lithium orotate, carbonate and chloride: pharmacokinetics, polyuria in rats. Br J Pharmacol 56 (4):: 399-402.
93. Frey BN, Valvassori SS, Réus GZ, Martins MR, Petronilho FC, et al. (2006) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Phsychiatry Neurosci 31 (5):: 326-32.
94. Nasrallah HA, Hopkins T, Pixley SK, (2010) Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats. Brain Res 1354: 23-29.
95. Fukazawa Y, Saitoh Y, Ozawa F, Ohta Y, Mizuno K, et al. (2003) Hippocampal LTP is accompanied by enhanced F-actin content within the dendritic spine that is essential for late LTP maintenance in vivo. Neuron 38: 447-460.